01/13/2025
7:06 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
3:22 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2024
3:24 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2024
3:59 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2024
3:05 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
3:40 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
11:15 AM | Kynam Capital Management, LP (Filed by)
Vera Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
8:35 AM | Avoro Capital Advisors LLC (Filed by)
Vera Therapeutics (Subject)
| Form SC 13G | |
11/12/2024
9:34 AM | FMR LLC (Filed by)
Vera Therapeutics (Subject)
| Form SC 13G/A | |
11/07/2024
7:00 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
6:49 PM | Longitude Capital Partners IV, LLC (Filed by)
Vera Therapeutics (Subject)
| Form SC 13D/A | |
|
10/31/2024
5:05 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
3:15 PM | Vera Therapeutics (Filer)
| Form 424B5 | |
10/29/2024
5:15 AM | Vera Therapeutics (Filer)
| Form 424B5 | |
10/28/2024
4:29 PM | Vera Therapeutics (Filer)
| Form S-3ASR | |
10/28/2024
4:30 PM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
3:37 PM | SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024
3:16 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/11/2024
3:05 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/09/2024
3:17 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024
8:01 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
3:05 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
3:45 PM | SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
3:38 PM | SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024
3:38 PM | SEIDENBERG BETH C (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024
3:36 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:19 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024
3:04 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
4:40 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
3:31 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
3:24 PM | Fordyce Marshall (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2024
3:36 PM | Vera Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
7:00 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2024
4:15 PM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:30 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
8:27 PM | Grant Sean (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/05/2024
8:32 PM | Grant Sean (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
8:55 PM | Vera Therapeutics (Filer)
| Form ARS | |
04/03/2024
4:00 PM | Vera Therapeutics (Filer)
| Form DEF 14A | |
04/03/2024
4:02 PM | Vera Therapeutics (Filer)
| Form DEFA14A | |
03/26/2024
7:35 PM | Vera Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
Wall St turns to THIS catalyst after Trump’s inauguration (Ad) Wall Street is already looking past Trump…
To a new catalyst on the near horizon that could be even bigger than his inauguration.
As soon as January 29th… So please watch this video now before the hammer falls and it’s too late. |
03/26/2024
6:57 PM | Sofinnova Venture Partners X, L.P. (Filed by)
Vera Therapeutics (Subject)
| Form SC 13D/A | |
03/25/2024
8:46 PM | Katabi Maha (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:54 PM | Katabi Maha (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
6:30 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
6:11 PM | Sofinnova Venture Partners X, L.P. (Filed by)
Vera Therapeutics (Subject)
| Form SC 13D/A | |
02/14/2024
3:57 PM | CITADEL ADVISORS LLC (Filed by)
Vera Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
2:21 PM | Ares Trading S.A. (Filed by)
Vera Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
11:49 AM | Kynam Capital Management, LP (Filed by)
Vera Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
9:05 AM | FMR LLC (Filed by)
Vera Therapeutics (Subject)
| Form SC 13G/A | |
02/05/2024
3:45 PM | Longitude Capital Partners IV, LLC (Filed by)
Vera Therapeutics (Subject)
| Form SC 13D/A | |
02/01/2024
4:58 PM | Katabi Maha (Reporting)
Vera Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
3:52 PM | Vera Therapeutics (Filer)
| Form 424B5 | |
01/30/2024
3:54 PM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2024
8:58 PM | Vera Therapeutics (Filer)
| Form S-3MEF | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Vera Therapeutics (Subject)
| Form SC 13G | |
01/29/2024
3:27 PM | Lin Celia (Reporting)
Vera Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
7:46 AM | Vera Therapeutics (Filer)
| Form 424B5 | |
01/29/2024
5:05 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2024
5:31 AM | Vera Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
